You are here: REHACARE Portal. Up-to-date. Archive. USA.
Complications of Type 2 Diabetes in Young People
The increasing prevalence of type 2 diabetes mellitus and its associated complications in young people mean better approaches and management of both are urgently needed, conclude authors of a Review published in this week’s issue of The Lancet.
The Review adds that the poor adherence of adolescents with type 2 diabetes to treatment programmes could place them at high-risk of developing these early complications.
The reports reviewed indicate that these complications are being identified at an early age and usually at the time of diagnosis. Furthermore, studies to date suggest that early onset of type 2 diabetes in adolescents is associated with a more rapid progression of complications than type 1 diabetes.
The authors say: “With the rise in prevalence of type 2 diabetes mellitus in adolescents, a rise in incidence of secondary co-morbidities – including hypertension, hyperlipidaemia, nephropathy and retinopathy – is anticipated.”
They add: “To date, reports of the epidemiology and natural history of secondary complications specifically in adolescents with type 2 diabetes have been scarce. Yet we must begin to understand this coming challenge.”
The chronic complications associated with type 2 diabetes explored in the Review include hypertension, nephropathy, retinopathy, dyslipidaemia, non-alcoholic fatty liver disease and neuropathy.
Psychiatric disorders can also be associated with type 2 diabetes – with one in five adolescents in a study from Philadelphia, USA, suffering from conditions such as depression, obsessive-compulsive disorder or one of a range of other neuropsychiatric diseases.
The authors conclude: “These findings, although still limited, suggest that we urgently need to develop approaches to awareness and early management of type 2 diabetes and associated abnormalities while designing long term studies to establish the value of early initiation of adjunctive treatments.”
REHACARE.de; Source: The Lancet
- More on The Lancet at: www.thelancet.com